These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22754355)

  • 1. The three dimensional Quantitative Structure Activity Relationships (3D-QSAR) and docking studies of curcumin derivatives as androgen receptor antagonists.
    Xu G; Chu Y; Jiang N; Yang J; Li F
    Int J Mol Sci; 2012; 13(5):6138-6155. PubMed ID: 22754355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
    Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
    Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment.
    Zhao X; Chen M; Huang B; Ji H; Yuan M
    Int J Mol Sci; 2011; 12(10):7022-37. PubMed ID: 22072933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolo[3,2-d]pyrimidine derivatives as type II kinase insert domain receptor (KDR) inhibitors: CoMFA and CoMSIA studies.
    Wu XY; Chen WH; Wu SG; Tian YX; Zhang JJ
    Int J Mol Sci; 2012; 13(2):2387-2404. PubMed ID: 22408460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
    Balupuri A; Balasubramanian PK; Cho SJ
    Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA, CoMSIA, HQSAR and Molecular Docking Analysis of Ionone-based Chalcone Derivatives as Antiprostate Cancer Activity.
    Sharma R; Dhingra N; Patil S
    Indian J Pharm Sci; 2016; 78(1):54-64. PubMed ID: 27168682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors.
    Wu X; Wu S; Chen WH
    J Mol Model; 2012 Mar; 18(3):1207-18. PubMed ID: 21695506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
    Dowlati Beirami A; Hajimahdi Z; Zarghi A
    J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
    Chen H; Yu YZ; Tian XM; Wang CL; Qian YN; Deng ZA; Zhang JX; Lv DJ; Zhang HB; Shen JL; Yuan M; Zhao SC
    Bioorg Med Chem; 2019 Jan; 27(1):133-143. PubMed ID: 30482547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
    Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
    Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents.
    Inturi B; Pujar GV; Purohit MN
    J Recept Signal Transduct Res; 2015; 35(5):468-78. PubMed ID: 26053507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents.
    Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T
    Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety.
    Chen H; Zhang J; Hu P; Qian Y; Li J; Shen J
    Bioorg Med Chem; 2019 Oct; 27(20):115081. PubMed ID: 31493989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico profiling the interaction mechanism of 2,5-diketopiperazine derivatives as oxytocin antagonists.
    Yang M; Luo J; Zeng Z; Yang L; Xu L; Li Y
    J Mol Graph Model; 2019 Jun; 89():178-191. PubMed ID: 30904734
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening.
    Liu J; Liu B; Guo G; Jing Y; Zhao G
    Anticancer Drugs; 2015 Aug; 26(7):747-53. PubMed ID: 25933245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship analysis of 3-phenylpyrazole derivatives as androgen receptor antagonists.
    Han W; Li J
    J Biomol Struct Dyn; 2020 Jun; 38(9):2582-2591. PubMed ID: 31232182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
    Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
    Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.